AlonsoI.G., MarinoE.L., Dominguez-GilA., TaberneroJ.M.. Pharmacokinetics of cefotiam during hemofiltration.Int J Cin Pharmacol Ther Toxicol1986; 24: 359–61.
2.
ArmendarizE., ChelluriL., PtachcinskiR.. Pharmacokinetics of amikacin during continuous veno-venous hemofiltration.Crit Care Med1990; 18: 675–6.
3.
GolperT.A., WedelS.K., KaplanA.A., SaadA.M., DontaS.T., PaganiniE.P.. Drug removal during continuous arteriovenous hemofiltration: theory and clinical observation.Int J Artif Organs1985; 8: 307–12.
4.
KellerE., BöhlerJ., Busse-GrawitzA., Reetze-BonordenP., KrummeB., SchollmeyerP.. Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients.Clin Nephrol1995; 43(suppl. 1): S20–S22.
5.
KrohU.F., DehneM.G., El-AbedK., FeussnerK.D., HofmannW., LennartzH.. Drug dosage during continuous hemofiltration: pharmacokinetics and practical implications.Contrib Nephrol1991; 93: 127–130.
6.
Reetze-BonordenP., BöhlerJ., KellerE.. Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations.Clin Pharmacokinetics1993; 24: 362–79.
7.
Reetze-BonordenP., BöhlerJ., KellerE., KöhlerC., SchollmeyerP.. Elimination of vancomycin in patients on continuous arteriovenous haemodialysis (CAVHD)Contrib Nephrol1991; 93: 135–9.
8.
VosM.C., VincentH.H., YzermannE.P.F.. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD).Intensive Care Med1992; 18: 182–285.
